Acular and Cipro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acular (ketorolac tromethamine) and Cipro (ciprofloxacin hydrochloride). Common drug interactions include bunion among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Acular and Cipro. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Acular?

Acular has active ingredients of ketorolac tromethamine. eHealthMe is studying from 1,125 Acular users. Check the latest studies of Acular.

What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.



On Jul, 17, 2026

33 people who take Acular and Cipro together, and have interactions are studied.

Acular and Cipro drug interactions.

What are the common drug interactions of Acular and Cipro, by gender? *:

female:

  1. Bunion (a painful swelling on the first joint of the big toe)
  2. Chronic kidney disease
  3. Dementia (madness)
  4. Duodenal ulcer
  5. Dyspnoea (difficult or laboured respiration)
  6. Gait disturbance
  7. Osteonecrosis (death of bone)
  8. Spinal compression fracture (fracture due to spinal compression on bone)
  9. Anxiety
  10. Bone callus excessive (excessive bony deposit formed between and around the broken ends of bone fractures)

male:

  1. Cardiac failure congestive
  2. International normalised ratio increased
  3. Cardiomyopathy (weakening of the heart muscle)
  4. Cholecystitis (infection of gallbladder)
  5. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  6. Depression
  7. Dizziness
  8. Dyspnoea (difficult or laboured respiration)
  9. Flatulence (flatus expelled through the anus)
  10. Fluid overload (too much fluid in the blood)

What are the common drug interactions of Acular and Cipro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abnormal weight gain
  2. Adverse reaction
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Cataract (clouding of the lens inside the eye)
  6. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Device expulsion
  10. Drug intolerance (drug sensitivity)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Dizziness
  2. Dyspnoea (difficult or laboured respiration)
  3. Flatulence (flatus expelled through the anus)
  4. Fluid overload (too much fluid in the blood)
  5. Hepatosplenomegaly (enlargement of both the liver and the spleen)
  6. Hypertension (high blood pressure)
  7. Hypertensive heart disease
  8. International normalised ratio increased
  9. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  10. Palpitations (feelings or sensations that your heart is pounding or racing)

60+:

  1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  2. Fall
  3. Multiple injuries
  4. Osteonecrosis (death of bone)
  5. Pain in extremity
  6. Spinal compression fracture (fracture due to spinal compression on bone)
  7. Surgery
  8. Unresponsive to stimuli
  9. Anaemia (lack of blood)
  10. Blood glucose increased

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 30.30%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 30.30%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 12.12%
  4. Osteoporosis (bones weak and more likely to break): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Acular and Cipro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acular and Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acular:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acular and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cipro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ketorolac tromethamine and ciprofloxacin hydrochloride (the active ingredients of Acular and Cipro, respectively), and Acular and Cipro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: